Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Colorectal Cancer Screening Market, by Type
1.4.2 Europe Colorectal Cancer Screening Market, by End-user
1.4.3 Europe Colorectal Cancer Screening Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.2.4 Geographical Expansions
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.3.2 Key Strategic Move: (Mergers & Acquisition: 2019, Jul – 2022, Dec) Leading Players
4.4 Porter’s Five Forces Analysis
Chapter 5. Europe Colorectal Cancer Screening Market by Type
5.1 Europe Colonoscopy Market by Country
5.2 Europe Stool-based Market by Country
5.3 Europe Colorectal Cancer Screening Market by Stool-based Type
5.3.1 Europe Fecal Immunochemical Test (FIT) Market by Country
5.3.2 Europe Fecal Occult Blood Test (FOBT) Market by Country
5.3.3 Europe Stool-DNA Test Market by Country
5.4 Europe Others Market by Country
Chapter 6. Europe Colorectal Cancer Screening Market by End-user
6.1 Europe Hospitals & Clinics Market by Country
6.2 Europe Clinical Laboratories Market by Country
6.3 Europe Diagnostic Imaging Centres Market by Country
6.4 Europe Others Market by Country
Chapter 7. Europe Colorectal Cancer Screening Market by Country
7.1 Germany Colorectal Cancer Screening Market
7.1.1 Germany Colorectal Cancer Screening Market by Type
7.1.1.1 Germany Colorectal Cancer Screening Market by Stool-based Type
7.1.2 Germany Colorectal Cancer Screening Market by End-user
7.2 UK Colorectal Cancer Screening Market
7.2.1 UK Colorectal Cancer Screening Market by Type
7.2.1.1 UK Colorectal Cancer Screening Market by Stool-based Type
7.2.2 UK Colorectal Cancer Screening Market by End-user
7.3 France Colorectal Cancer Screening Market
7.3.1 France Colorectal Cancer Screening Market by Type
7.3.1.1 France Colorectal Cancer Screening Market by Stool-based Type
7.3.2 France Colorectal Cancer Screening Market by End-user
7.4 Russia Colorectal Cancer Screening Market
7.4.1 Russia Colorectal Cancer Screening Market by Type
7.4.1.1 Russia Colorectal Cancer Screening Market by Stool-based Type
7.4.2 Russia Colorectal Cancer Screening Market by End-user
7.5 Spain Colorectal Cancer Screening Market
7.5.1 Spain Colorectal Cancer Screening Market by Type
7.5.1.1 Spain Colorectal Cancer Screening Market by Stool-based Type
7.5.2 Spain Colorectal Cancer Screening Market by End-user
7.6 Italy Colorectal Cancer Screening Market
7.6.1 Italy Colorectal Cancer Screening Market by Type
7.6.1.1 Italy Colorectal Cancer Screening Market by Stool-based Type
7.6.2 Italy Colorectal Cancer Screening Market by End-user
7.7 Rest of Europe Colorectal Cancer Screening Market
7.7.1 Rest of Europe Colorectal Cancer Screening Market by Type
7.7.1.1 Rest of Europe Colorectal Cancer Screening Market by Stool-based Type
7.7.2 Rest of Europe Colorectal Cancer Screening Market by End-user
Chapter 8. Company Profiles
8.1 Novigenix SA
8.1.1 Company Overview
8.1.2 SWOT Analysis
8.2 Eiken Chemical Co., Ltd.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Research & Development Expenses
8.3 Clinical Genomics Pathology, Inc.
8.3.1 Company Overview
8.3.2 Recent strategies and developments:
8.3.2.1 Partnerships, Collaborations, and Agreements:
8.3.3 SWOT Analysis
8.4 Exact Sciences Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisition and Mergers:
8.4.6 SWOT Analysis
8.5 Epigenomics AG
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 SWOT Analysis
8.6 BioMerieux S.A.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Acquisition and Mergers:
8.6.6 SWOT Analysis
8.7 Olympus Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Product Launches and Product Expansions:
8.7.5.3 Acquisition and Mergers:
8.7.6 SWOT Analysis
8.8 Sysmex Corporation
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Regional Analysis
8.8.4 Research & Development Expense
8.8.5 SWOT Analysis
8.9 Siemens Healthineers AG (Siemens AG)
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.9.4.1 Acquisition and Mergers:
8.9.5 SWOT Analysis
8.10. Fujifilm Holdings Corporation
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
8.10.5.2 Product Launches and Product Expansions:
8.10.5.3 Geographical Expansions:
8.10.6 SWOT Analysis
Unique Offerings 